BEHCET’S SYNDROME MARKET ANALYSIS

Regional Analysis

Global Behcet’s Syndrome Market – Regional Insights

North America is anticipated to hold dominate market share the behcet’s syndrome market growth during the forecast period owing to increasing use of different diagnostic criteria for behcet’s syndrome. For instance, in November 2017, according to European Journal of Rheumatology, new international criteria for Behçet's Disease (ICBD) were suggested, emphasizing oral, genital, and ophthalmic involvement and allowing for the incorporation of vascular and neurological involvement as a reference for behcet’s syndrome diagnosis. Neurologic and gastrointestinal symptoms were observed in a considerably larger percentage of individuals in the United States.

Asia pacific is anticipated to witness lucrative market growth during the forecast period owing to increasing prevalence of the behcet’s syndrome. It is observed commonly among populations living in Japan and China. It is frequently noted between the 30th and 45th degree latitudes populations. For instance, according to a research study published in May 2021, in Journal of Clinical Rheumatology and Immunology, in East Asia, the prevalence is stated to be 16/100,000 in Japan, 35/100,000 in Korea, and 14/100,000 in China, which is expected to propel the behcet’s syndrome market growth during the forecast period in the region.